SCHEMBL9364677

SCHEMBL9364677

COc1ccc2c(c1)[nH]c(=O)c(=O)n2O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.46
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
CASP1 P29466 1/20 0.46
CASP7 P55210 1/20 0.46
ALDH1A1 P00352 6/20 0.44
GAA P10253 2/20 0.44
POLB P06746 1/20 0.44
DAO P14920 2/20 0.44
PDE3B Q13370 2/20 0.41
PDE3A Q14432 2/20 0.41
HPGD P15428 4/20 0.40
HSD17B10 Q99714 3/20 0.40
GFER P55789 2/20 0.40
MAPT P10636 2/20 0.40
TSHR P16473 1/20 0.40
NPSR1 Q6W5P4 2/20 0.39
HCRTR1 O43613 1/20 0.39
HTT P42858 1/20 0.39
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9365381 0.88 ALDH1A1 (0.48) KDM4EMEN1KMT2ACASP1CASP7
SCHEMBL9395591 0.83 GRIA1 (0.53) KDM4EMEN1KMT2AALDH1A1GAA
SCHEMBL9741963 0.79 KDM4E (0.43) KDM4EALDH1A1GAAPOLBPDE3B
SCHEMBL9365003 0.79 DAO (0.70) KDM4EALDH1A1DAOHSD17B10
SCHEMBL9368432 0.78 GRIN2D (0.56) KDM4EALDH1A1GAAPOLBDAO
SCHEMBL8138622 0.76 DAO (0.70) KDM4EDAO
SCHEMBL9395728 0.73 GRIA1 (0.53) KDM4EMEN1KMT2AALDH1A1GAA
SCHEMBL8569221 0.73 TP53 (0.62) TP53
SCHEMBL1857924 0.72 LMNA (0.57) KDM4EMEN1KMT2AALDH1A1PDE3B
SCHEMBL12677211 0.72 HSD17B10 (0.66) KDM4EMEN1KMT2ACASP1CASP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0377112-B1 Quinoxaline compounds and their preparation and use NOVO NORDISK AS (DK) 1994-08-24 EP disclosed
US-5061706-A 2,3-QUINOXALINEDIONES FOR USE AS NEUROLEPTICS NOVO NORDISK A/S (DK) 1991-10-29 US disclosed
EP-0377112-A1 Quinoxaline compounds and their preparation and use NOVO NORDISK A/S (DK) 1990-07-11 EP disclosed